Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) vs Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
Side-by-side comparison of two grants.
| Attribute | Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | $350K | — |
| Deadline | Closes 2026-11-06 | Closes 2027-07-17 |
| Region | US | US |
| Sector | Education | Education |
| Funder | National Institutes of Health | National Institutes of Health |
| Who it's for | researchers, students, government | researchers, students, government |
noindex — no measured search demand